Differential expression of an alternative splice variant of IL-12Rβ1 impacts early dissemination in the 1 mouse and associates with disease outcome in both mouse and humans exposed to tuberculosis 
Abstract. (244 words) 31
Experimental mouse models of TB suggest that early events in the lung impact immunity. Early events 32 in the human lung in response to TB are difficult to probe and their impact on disease outcome is 33 unknown. We have shown in mouse that a secreted alternatively-spliced variant of IL-12Rβ1, lacking the 34 transmembrane domain and termed ΔTM-IL-12Rβ1, promotes dendritic cell migration to the draining 35 lymph node, augments T cell activation and limits dissemination of M. tuberculosis (Mtb) . We show here 36 that CBA/J and C3H/HeJ mice (both highly susceptible to Mtb) express higher levels of ΔTM-IL-12Rβ1 37 than resistant C57BL6 mice and limit early dissemination of Mtb from the lungs. Both CD11c + cells and 38 T cells express ΔTM-IL-12Rβ1 in humans, and mice unable to make ΔTM-IL-12Rβ1 in either CD4 or 39
CD11c expressing cells permit early dissemination from the lung. Analysis of publically available blood 40 transcriptomes indicates that pulmonary TB is associated with high ΔTM-IL-12Rβ1 expression and that 41 of all IL-12 related signals, the ΔTM-IL-12Rβ1 signal best predicts active disease. ΔTM-IL-12Rβ1 42 expression reflects the heterogeneity of latent TB infection and has the capacity to discriminate between 43 latent and active disease. In a new Chinese TB patient cohort, ΔTM-IL-12Rβ1 effectively differentiates 44 TB from latent TB, healthy controls and pneumonia patients. Finally, ΔTM-IL-12Rβ1 expression drops in 45 drug-treated individuals in the UK and China where infection pressure is low. We propose that ΔTM-IL-46 12Rβ1 regulates early dissemination from the lung and that it has diagnostic potential and provides 47 mechanistic insights into human TB. 48
Introduction 50
Tuberculosis (TB) remains a critical worldwide health issue despite significant public health and research 51 efforts 1 . Key elements in our failure to limit this disease are the large number of people infected with the 52 bacterium, Mycobacterium tuberculosis (Mtb) which causes disease, the lack of an effective vaccine 53 against pulmonary TB and the need for prolonged and multiple drug treatments . Understanding how the IL-12 receptor complex contributes to protection and disease is 61 therefore critical. While the major function of this receptor complex is to promote IFN-γ production and 62 consequent macrophage activation 4, 6 , we have identified a novel role for IL-12p40 and IL-12Rβ1 in 63 initiation of early events within the lung following low dose aerosol exposure to Mtb 7, 8 .
64
Experimental mouse models of aerosol exposure to Mtb indicate that the rapidity of bacterial 65 dissemination and early activation of T cells in the draining lymph node and spleen contribute to effective 66 control of lung infection 9, 10, 11 . Specifically, slow dissemination of bacteria leads to delayed T cell 67 activation and delayed recruitment of these T cells 12 . This delay results in T cells arriving at the infected 68 foci after the inflammatory response to the bacteria has begun and where the inflamed environment limits 69 the efficacy of the T cell response in situ 10, 13 . We have shown that the cytokine IL-12p40 is expressed 70 early following Mtb exposure 8 and that if dendritic cells do not express IL-12p40 then they do not become 71 motile when exposed to Mtb, do not migrate from the lung to the draining lymph node and do not drive 72 naive T cell activation 7 . Dendritic cells in the lungs of Mtb-exposed mice produce not only IL-12p40 but 73 also an alternative splice variant of IL-12Rβ1 which lacks the transmembrane domain and which we have 74
. This splice variant was identified when the receptor was first described 14 howeverits function was not appreciated until our studies in Mtb 8, 15 . . These data sets are available from areas of the world where 88 the chance of infection (or infection pressure) varies due to the incident rate of disease; thus South Africa 89 has a high incidence of TB at 781/100,000 and thus has high infection pressure, China has moderate 90 incidence at 65/100,000 (modest infection pressure) and the UK has an overall low incidence 91 (10/100,000) with some higher areas in London and the Midlands but at best only a low infection 92 pressure 1 . This variety in the source of transcriptomic data sets allows for global insight into how specific 93 gene expression profiles are associated with disease and also allows infection pressure to be considered 94 as a factor in this association. Importantly for our study, while the commercially available arrays have 95 probes sets specific for IL12RB1 these sets contain probes uniquely specific for either the full length or 96 the alternatively spliced isoform. Combining the signal for the full and the alternatively spliced isoform 97 into one signal for IL12RB1 obfuscates which isoform is expressed and therefore manual curation is 98 required in order to differentiate these signals. 99
To address the potential role of the alternative splice variant of IL-12Rβ1 in TB we have combined mouse 100 mechanistic studies with analysis of both published and novel transcriptomic profiles. We have found thatwith our transgenic mice, which upon FLP and CRE recombination excise introns 13 and 14 of the il12rb1 128 gene 15 . Confirmation of excision was undertaken with PCR in each case. 129
Infection Mtb strain H37Rv was grown in Proskauer Beck medium containing 0.05% Tween 80 to mid-130 log phase and frozen at -70°C. Mice were infected with a low dose of bacteria (~75 CFU) using a Glas-131
Col airborne infection system as previously described 25 . At day 1 and day 15 post-challenge, mice were 132 killed by CO2 asphyxiation, the organs were aseptically excised and individually homogenized in saline. 133
Organ homogenates were subsequently plated on nutrient 7H11 agar (BD Biosciences) for 3 weeks at 134 37°C, at which point CFU were counted. 135
Quantitative PCR. RNA was generated from mouse tissue or human cells using the RNAeasy kit and 136 was reverse transcribed with an RT Kit from Life technologies -now ThermoFisher Scientific). RT-PCR 137 was performed to generate Ct values which were normalized to the housekeeping gene signal and then 138 applied to a standard curve to determine copy number for each isoform of human and mouse IL-12Rβ1 139 transcript generated from a specific template 26 .
140
Human monocyte derived dendritic cells. Discarded filters from blood donor clinic were harvested for 141 peripheral blood cells and the CD14+ cells were purified using magnetic beads (Miltenyi). CD14+ cells 142
were seeded at 2x10 6 /ml into wells in RPMI containing 10% FCS and stimulated with 4000IU/ml GM-CSF 143 and 1000IU/ml IL-4 (both cytokines from Peprotech). Media was refreshed at 3 days and the cells were 144 used for experiments at day 5. 145
Microarray data from publically available databases. To evaluate gene expression of ΔTM-IL-12Rβ1 in 146 TB, we used the transcriptome-microarray datasets available in public repositories. Briefly, public 147 databases of Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) and ArrayExpress 148 (https://www.ebi.ac.uk/arrayexpress) were searched with the keywords 'Tuberculosis, Patients'. A total 149 of 59 data series (58 in GEO and 19 in ArrayExpress -with 16 overlapping) were retrieved from the 150 search. We used the following exclusion criteria:-samples other than blood or blood derived cells, array 151 platform lacking specific probe for ΔTM-IL-12Rβ1, series lacking non-comorbid TB conditions, lacking 152 adult TB subjects, with less than 3 replicated samples for one condition and repeat arrays, we identified16 arrays for further analysis. Full texts of the associated articles were evaluated for details on patient 154 selection, demographics, sampling and RNA analysis. Six out of 16 were further excluded as the median 155 centered across samples was not zero 27 and final analysis was carried out on 10 datasets (Table 2) . 156
Processing of microarray dataset. Out of 10 data sets, 7 were generated on Illumina and 3 were on the 157 Affymetrix platform (Table 2 ). All 3 Affymetrix data series were generated on the same platform. The raw 158
.cel files were converted to expression values using GC-RMA package read by 'affy' package on 159
Bioconductor

21
. Associated packages and libraries used were "hgu133plus2.db", "hgu133plus2cdf". R-160 studio version-1.0.143.0 using Bioconductor libraries and R statistical packages were used for data 161 analysis. Processed data matrices were exported into tab delimited txt files. 162
For Illumina data series matrix, those including non-log transformed and normalized data were analyzed 163 using 'GEOquery' and 'lumi' package 28, 29 . For datasets having transformed and normalized values in 164 series matrix, raw (non-normalized data) data files were downloaded from the GEO_supplementary files 165 followed by processing using 'lumi' package. Briefly, data sets were processed, background corrected, 166 log-2 transformed and then normalized using 'quantile' method. The processed data file was saved as 167 tab delimited .txt file. 
Expression of ΔTM-IL-12Rβ1 in the lung associates with reduced dissemination of Mtb from the lung to 200
the periphery. We knew from our previous studies that the ΔTM-IL-12Rβ1 message was induced early in 201 the lungs of C57BL/6J (B6) mice exposed to low dose aerosol infection 8 . We also knew that the global 202 inability to make the ΔTM-IL-12Rβ1 resulted in increased dissemination of bacteria to the periphery and 203 reduced ability to generate IFN-γ producing T cells 15, 18 . We wanted to determine whether this observation 204 was unique to the resistant B6 strain of mouse or if there was differential expression in mice which are 205 substantially more susceptible to the low dose aerosol challenge 38 . To achieve this we infected resistant 206 B6 and susceptible CBA/J (CBA) and C3H/HeJ (C3H) mice in the same aerosol chamber and determined 207 bacterial burden (Fig 1 A) and expression of the full length and ΔTM-IL-12Rβ1 (Fig 1B) at day 15 post 208 infection. We found that while the bacterial burden in the lung was not markedly dissimilar between the 209 strains of mice at this time point there was a much greater range of dissemination to the mediastinal 210 lymph node (MLN) and that there was no detectable dissemination to the spleen or liver in the C3H and 211 CBA mice (Fig 1A) . When we measured the copy number of both full length and ΔTM-IL-12Rβ1 mRNA 212
by quantitative RT-PCR we found that while all three strains expressed a small but measurable amount 213 of full length mRNA, the C3H and CBA mice made a much greater amount of ΔTM-IL-12Rβ1 in their 214 lungs than did the B6. While there was modest induction of the ΔTM-IL-12Rβ1, the baseline level of 215 mRNA for ΔTM-IL-12Rβ1 was already high in both the CBA and C3H suggesting that expression may be 216 regulated by a homeostatic factor unrelated to Mtb infection. Regardless of the mechanism that drives 217 baseline induction of ΔTM-IL-12Rβ1, it is clear that a high level of expression is associated with reduced 218 dissemination of bacteria from the lung to the periphery. 219
Expression of ΔTM-IL-12Rβ1 can be induced in human dendritic cells and is impacted by TB in myeloid 220
cells and lymphocytes in blood. Having identified an association between high level expression of ΔTM-221 IL-12Rβ1 and reduced dissemination in mice with increased susceptibility to TB we wanted to determine 222 expression of ΔTM-IL-12Rβ1 in specific cells in humans with and without TB. In a first study we extended 223 our observation that human monocyte-derived dendritic cells express ΔTM-IL-12Rβ1 in response to Mtb 8 224 by determining the kinetics of the response to live Mtb exposure in monocyte-derived dendritic cells from 225 several anonymous blood donors. By measuring the copy number of full length and ΔTM-IL-12Rβ1 226 mRNA using quantitative RT-PCR we were able to generate a ratio between the two signals and compare 227 the response of individual donors. We found that donors made a strong ΔTM-IL-12Rβ1 response between 228 3 and 6 hours which waned by 9 hours (Fig 2 A) . These data suggest that Mtb drives an acute but not 229 prolonged expression of ΔTM-IL-12Rβ1 in this cell type. We also probed the gene-expression array datain monocytes, neutrophils and lymphocytes that had been isolated from the blood of healthy control and 231 those with active pulmonary TB 31 . We found that the signal from the probe specific for the ΔTM-IL-12Rβ1 232 was more highly expressed in monocytes and neutrophils from TB patients relative to controls (Fig 2 B)  233 and that while the CD4 and CD8 T cell signals independently failed to achieve the statistical threshold for 234 significance, when the data sets were combined and analyzed as T lymphocytes, they were significantly 235 different (average log2 intensity: PTB 8.145+/-0.10, n=14 versus HC 7.72+/-0.16, n=8; P=0.0294). These 236 data indicate that exposure to Mtb and active TB induces expression of ΔTM-IL-12Rβ1 in human cells of 237 both myeloid and lymphoid origin. 238
Inability of either CD11c or CD4 expressing cells to produce ΔTM-IL-12Rβ1 results in increased 239
dissemination of Mtb from the lung to the periphery following aerosol infection. We see expression of the 240 ΔTM-IL-12Rβ1 in both myeloid and lymphoid cells in blood from TB patients ( Fig 2B) and we know that 241 a global inability to make ΔTM-IL-12Rβ1 reduces control of dissemination 15 while high expression is 242 associated with inhibition of dissemination of Mtb (Fig 1) . We wanted therefore to determine whether 243 myeloid or lymphoid cell expression of ΔTM-IL-12Rβ1 is responsible for the control of dissemination of 244 bacteria from the lung to the periphery. To do this we crossed our transgenic mouse, which excises exons 245 13 and 14 in a FLP/CRE dependent manner resulting in expression of the full length IL-12Rβ1 without 246 the structure to splice the ΔTM-IL-12Rβ1 15 to mice expressing Cre under the CD11c or CD4 promoter. 247
We infected the mice via aerosol and determined bacterial burden in the lungs and periphery at day 15 248 post infection (Fig 2C) . We found that while the bacterial burden in the lung was not affected by cell 249 specific loss of ΔTM-IL-12Rβ1 expression, there was a significant increase in the bacterial burden in the 250 liver of mice lacking ΔTM-IL-12Rβ1 in both CD11c and CD4 expressing cells (Fig 2C) . While the mean 251 number of bacteria in the MLN was not significantly different, the range of bacterial numbers was much 252 increased for the mice lacking ΔTM-IL-12Rβ1 in both CD11c-and CD4-expressing cells. Further, while 253 significance was seen for increased dissemination to the spleen in mice lacking ΔTM-IL-12Rβ1 in CD4-254 expressing cells, there was a trend to increased dissemination in the mice where ΔTM-IL-12Rβ1 was 255 deleted in CD11c + cells. These data support the hypothesis that cells of both the lymphoid and myeloidlineage produce ΔTM-IL-12Rβ1 in response to infection and that while the lymphoid compartment seems 257 to mediate the strongest effect, there is a measurable role for myeloid-derived ΔTM-IL-12Rβ1 in TB 258
control. In preliminary data we find that absence of ΔTM-IL-12Rβ1 in CD11c expressing cells results in 259 disruption of cytokine balance in the lung resulting in more IL-12p40 and more IL-10 (data not shown). 260
Meta-analysis of transcriptomic data reveals an association between PTB and expression of the ΔTM-IL-261
12Rβ1 in human blood. We observe that Mtb induces ΔTM-IL-12Rβ1 expression in human cells (Fig 2A)  262 and that purified cells from the blood of TB patients express ΔTM-IL-12Rβ1 (Fig 2B) . We also observe 263 an association between ΔTM-IL-12Rβ1 expression and dissemination from the lung to the periphery in 264 the experimental mouse model (Fig 1 and Fig 2C) . Together the data support analysis of ΔTM-IL-12Rβ1 265 expression in human disease. To achieve this we used defined criteria to select publically available array 266 data sets and obtained 10 data sets from 5 countries, 3 continents and 4 platforms ( Table 2) 24, 31, 39, 40, 41 . 267
In both Illumina and Affymetrix array platforms there are 3 probes representing detection of IL12RB1 268 transcription, one of which is specific for the full length transcript, one specific for the ΔTM-IL-12Rβ1 and 269 one that can detect both. To determine what each of the probes contributes to the observed total 270 IL12RB1 signal, we analyzed the raw data for each probe in 4 array data sets (Fig 3) . This analysis 271 revealed that for more than 90% of the samples, the signal from the probe specific for the full length IL-272 12Rβ1 transcript is negligible (i.e. the raw probe signal is insignificant) (Fig 3, FL-IL12Rβ1 ) while the 273 signal for ΔTM-IL-12Rβ1 is detectable in almost all samples (Fig 3, ΔTM-IL-12Rβ1 ). The intensity of the 274 signal for the probe specific for ΔTM-IL-12Rβ1 is highly correlated with the signal from the probe which 275 detects both the full length and ΔTM-IL-12Rβ1 transcripts, while the signal for the probe specific for the 276 full length transcript correlates with both signals to a much lower degree (Table 3) . These analyses 277
suggest that blood cells express the ΔTM-IL-12Rβ1 transcript in significant amounts and that this 278 transcript is the dominant one. 279
Higher expression of the ΔTM-IL-12Rβ1 transcript correlates with pulmonary TB. We see a specific signal 280
for ΔTM-IL-12Rβ1 in transcriptional data sets from human blood (Fig 3) and we know that this molecule 281 is associated with altered disease outcomes in the experimental mouse model (Fig 1 and 2) . Theseobservations support an in depth analysis of the transcriptional data sets from individuals with pulmonary 283 TB and their controls. To achieve this we processed, transformed and normalized the raw data from the 284 transcriptional arrays identified in Table 2 Figure 4A ). One data set in South Africa showed a trend but did not quite make 288 significance (GSE19442) 31 and the data in Indonesia 40 had a very small difference as might be expected 289 as the only difference between the groups was the absence of active symptoms for TB (i.e. non TB rather 290 than healthy control). Despite the small difference the data was not variable and thus reached 291 significance statistically. These data demonstrate that ΔTM-IL-12Rβ1 expression in the blood is 292 associated with active pulmonary TB. 293
Expression of the splice variant in the blood reflects the heterogeneity of latent TB infection. While the 294
ΔTM-IL-12Rβ1 transcript clearly associates with pulmonary TB (PTB), it is variably able to discriminate 295
between latent TB infection (LTB) and PTB (Fig 4A) with 3 of 7 studies showing discrimination but no 296 association with location. One study showed very clear discrimination (China GSE 54992) 24 and this may 297 reflect the fact that this resulted from isolated PBMC rather than whole blood or may just reflect the 298 difference in the platform. These data suggest that the ΔTM-IL-12Rβ1 may have the capacity to 299 discriminate between LTB and PTB but work needs to be done to improve the signal. Within the three 300 studies which showed the ability to discriminate between LTB and PTB we investigated whether the ΔTM-301 IL-12Rβ1 signal was the strongest IL-12-related signal capable of discriminating between infection 302 outcomes. To do this we generated a data matrix using array signals from IL12A, IL12B, IL12RB1 and 303 IL-12RB2 as well as ratios of each set of signals as variables to see how well they differentiated between 304 groups. The top three performing variables based on area under the curve (AUC) or receiver operating 305 characteristic (ROC) curve capable of discriminating between control and PTB, LTB and PTB and LTB 306 and control are shown in Table 4 . The signal for ΔTM-IL-12Rβ1 either alone or as a ratio with other 307 members of the IL-12 family appears in the top three for all three arrays and for all three discriminatoryactivities. These analyses demonstrate that the ΔTM-IL-12Rβ1 signal has the potential to be a diagnostic 309 tool and should be studied further. 310
To extend our analysis of array data we analyzed RNA-Seq data generated from the RNA used in the 311
GSE19444 UK
31,30 for transcription of ΔTM-IL-12Rβ1 and found that as for array data, the ΔTM-IL-12Rβ1 312 signal discriminates between PTB and controls, the ΔTM-IL-12Rβ1 signal also discriminates between 313 LTB and controls (Fig 4B) . Importantly, we identify those samples identified as outliers in previous 314 analyses 31, 30 by open circles (Fig 4B) which show low expression of ΔTM-IL-12Rβ1 in the PTB outliers 315 and high expression in 3 of 5 in the LTB outliers suggesting that the ΔTM-IL-12Rβ1 signal may be 316 associated with the discriminatory gene-signature identified previously 31, 30 . 317
Finally, we wanted to test the predictive and discriminatory power of the ΔTM-IL-12Rβ1 signal in a test 318 patient cohort in China. To do this we probed the RNA from whole human blood using a targeted array 319 capable of measuring the IL-12Rβ1 signal. We found that while the LTB cohort had a more variable signal 320 than the controls, there was no significant difference between the means for these two populations and 321 the IL-12Rβ1-specific signal discriminated effectively between control and PTB, LTB and PTB, PTB and 322 pneumonia (Fig 4C) . These data further support the utility of the ΔTM-IL-12Rβ1 signal to discriminate 323 between PTB and LTB and PTB and other diseases. 324
The ΔTM-IL-12Rβ1 signal decreases upon treatment in areas of low infection pressure. Because we see 325 a difference in the ΔTM-IL-12Rβ1 signal between controls and PTB we reasoned that the ΔTM-IL-12Rβ1 326 may provide a signal indicating that treatment is effective. To determine if this was the case, we analyzed 327 the transcriptome sets containing data from treated individuals from areas of low infection pressure (UK, 328 overall incidence rate 10/100,000 -but with pockets of moderate infection pressure), moderate infection 329 pressure (China, incidence rate 64/100,000) and high infection pressure (South Africa, incidence rate 330 781/100,000). We found that in the UK and China an early (8-12 weeks) drop in the ΔTM-IL-12Rβ1 331 signal was seen during treatment, which was sustained long term (Fig 5, top graphs) . In contrast, in two 332 studies in South Africa no sustainable or reproducible drop in signal was seen over the population during 333 treatment (Fig 5, bottom graphs) . These data suggest that the signal for ΔTM-IL-12Rβ1 may be useful todetect treatment success in situations where the risk of reinfection is low, but it may reflect repeated 335 infection where reinfection risk is high. Determining when and how the ΔTM-IL-12Rβ1 is expressed in 336 the lungs of those recently exposed to TB is therefore an important undertaking. 337
338
Discussion 339
We show here that the ΔTM-IL-12Rβ1 is a significant indicator of active TB in human populations across 340 the globe, that it can discriminate between latent and active TB under some conditions and that it drops 341 during drug treatment in areas where the risk of reinfection is low. These observations are valuable and 342 suggest that this gene transcription signal can contribute to the development of sensitive and specific 343 modular transcriptional signatures 30 capable of defining the risk of TB development in those infected with 344 the bacterium. The goal for these signatures is to eventually turn the marked heterogeneity of latent 345 infection from a black box into a fully defined continuum with distinct transcriptional markers capable of 346 allotting individuals into low, mid and high risk of progression. In addition to this goal however the data 347 we report here also highlight the potential for the ΔTM-IL-12Rβ1 signal to inform us about the 348 mechanisms underlying the development and control of TB in the human lung. 349
In considering the early events in the TB-exposed lung, the invading bacteria is unlikely to meet any 350 activated macrophages or T cells when it first arrives and thus for the acquired immune response to be 351 initiated, the bacteria must migrate to the draining lymph node 12 . This migration is slow to occur and this 352 delay in activation and arrival of T cells allows the bacteria to grow unrestrained for up to 2 weeks in the 353 B6 mouse 9, 42 . Cytokines and chemokines capable of initiating early responses are therefore key to the 354 rapidity of the response and to eventual outcome 43 . We know that IL-12p40 is expressed very early 355 following Mtb infection and that its production precedes production of IL-23 or IL-12p35 suggesting that 356 it functions alone 7, 8 . We also know that type 1 IFN, IL-1, IL-10 and IL-12 cross regulate each other in 357 response to Mtb infection both in vitro and in vivo 7 44, 45, 46 and that the relative level of these cytokines 358 at the initiation of infection has the potential to impact the initiation of immunity. Our data reported here 359 suggest that the very high expression of the ΔTM-IL-12Rβ1 in the C3H and CBA mice may sequester IL12p40, which we know aids in overcoming the IL-10-induced resistance to migration in Mtb-exposed 361 dendritic cells 7 . This inhibition may then severely limits the migration of bacteria from the lung to the 362 periphery -as is seen in the CBA/J and C3H mice. In turn this delay then results in slow induction of T 363 cells thus leading to the observed higher susceptibility of these mice strains to Mtb 38 . In contrast, total 364 lack of the splice variant results in slightly higher dissemination of bacteria from the lung 15 and this effect 365 can be seen if either myeloid or lymphoid cells lack the ΔTM-IL-12Rβ1. The increased effect of the 366 absence of the ΔTM-IL-12Rβ1 in CD4 cells may reflect the role of the ΔTM-IL-12Rβ1 in augmenting IL-367 12p70-induced IFN-γ production in T cells 15, 18 , while the impact of the loss of ΔTM-IL-12Rβ1 in the CD11c 368 expressing cells may reflect the disruption of protective cytokine balance at the beginning of infection. 369
The very early but short lived ΔTM-IL-12Rβ1 response of the human dendritic cells to live Mtb infection 370
suggests that the signal is highly regulated and that sustained expression in myeloid cells may reflect 371 ongoing exposure to live bacteria. In this regard, our data showing increased expression of ΔTM-IL-372 12Rβ1 signal in the blood of active TB patients suggests that myeloid cells expressing this signature may 373 have been exposed to live bacteria in the recent past. Similarly, the drop in ΔTM-IL-12Rβ1 signal seen 374 during drug treatment may reflect removal of live bacteria from the body and therefore the loss of 375 stimulation for the signal. If one considers the infection pressure in the areas where the ΔTM-IL-12Rβ1 376 signal drops following drug treatment, it is possible that there is little re-exposure to drive the signal up 377 again but in areas where re-infection is likely there will be repeated exposures in the lung and the ΔTM-378 IL-12Rβ1 will be maintained despite drug treatment. 379 IL-12Rβ1 exhibits a marked degree of variability at the genomic 5 , transcriptional 47 and splice variant 380 level 17 suggesting that it is a highly flexible receptor with the capacity to both stimulate and inhibit cellular 381 responses. Our observation that ΔTM-IL-12Rβ1 is secreted 15 suggests that it acts to sequester cytokine 382 and regulate activation of cells however it appears to drive activation of T cells 8, 18 and is a positive 383 regulator of immunity. Its effects in mouse lungs suggests that, just as for type 1 IFN 48 a little bit is good 384 and required for optimal control of bacterial dissemination but too much completely limits dissemination 385 and hampers induction and expression of protective immunity.
Our data demonstrate that determining the underlying mechanisms whereby the alternative splice variant 387 of IL-12Rβ1 impacts TB immunity in both mouse and man should be pursued. The data also support 388 further investigation into the best use of the transcriptional ΔTM-IL-12Rβ1 signal in defining the 389 heterogeneity of latent TB infection. 390
Figure Legends 391
Figure 1 Mice susceptible to Mtb infection express high levels of ΔTM-IL-12Rβ1 and limit early 392 dissemination form the lung to the periphery. Mice were infected using an aerosol chamber capable 393 of reproducibly delivering approximately 75 colony forming units to each mouse. Mice were housed for 394 15 days after challenge and then the organs plated for determination of colony forming units (CFU) (Fig  395   1A ) and the copy number of mRNA for the full length IL-12Rβ1 (FL-IL-12Rβ1) and the alternative splice 396 variant ΔTM-IL-12Rβ1 determined by quantitative RT-PCR (Fig 1B) . All data points are shown from 2 397 independent experiments (Fig 1A) or one data set representative of two total experiments (Fig 1B) . 398
Statistical significance was determined using one way ANOVA comparing all groups; n = 8 per group (Fig  399   1A ) and n= 4 per group repeated twice (Fig 1B) . *P<0.05, **P<0.01, ***P<0.001. 400
Figure 2 ΔTM-IL-12Rβ1 is expressed by lymphoid and myeloid human cells and its absence in 401
CD11c or CD4 expressing cells compromises control of dissemination in mice. Human myeloid 402 derived dendritic cells were generated from anonymous blood donors and exposed to live Mtb for 24 403 hours. RNA was extracted over the time course and analyzed for the copy number of mRNA for the full 404 length IL-12Rβ1 (FL-IL-12Rβ1) and the alternative splice variant ΔTM-IL-12Rβ1 by quantitative RT-PCR. 405
The ratio of ΔTM-IL-12Rβ1 to FL-IL-12Rβ1 was determined for each donor and the data points represent 406 the mean of 4-7 values per time point (Fig 2A) . Array data from GSE19443 was analyzed for expression 407 of the ΔTM-IL-12Rβ1 in cells purified from the blood of healthy controls (Cont) and TB patients (PTB). 408
Data points are all shown with an n=4-7, the difference between the means was determined by Students 409 t test, * P<0.05 (Fig 2B) . Mice either intact (B6KI) lacking the ability to generate the ΔTM-IL-12Rβ1 in 410 either CD11c (CD11cCre) or CD4 (CD4Cre) expressing cells were infected with Mtb and the bacterial 411 burden determined at day 15 as described for Fig 1. All data points are shown for 2 independent 412 experiments, n=8, differences between the mean were determined by ANOVA with all columns being 413 compared. *P<0.05, **P<0.01, ***P<0.001 (Fig 2C) . 414 Figure 3 . The majority of the IL-12Rβ1 signal seen in microarray data is derived from the ΔTM-IL-415 12Rβ1 specific probe. Raw data was manually curated and the signal for each probe analyzedseparately for each of 4 microarray data sets. The raw fluorescent intensity for each sample and different 417 IL-12Rβ1 isoform specific probe is shown. The probe intensity for the FL-IL-12Rβ1 was not considered 418 to be significant for the majority of samples and over all of the data sets whereas the signal from the 419 probe specific for the ΔTM-IL-12Rβ1 was significantly expressed in all samples. 420 Figure 4 . Expression of ΔTM-IL-12Rβ1 in blood associates with active pulmonary TB and is 421 variably associated with latent TB. Microarray data from publically available databases was analyzed 422 for the signal specific for ΔTM-IL-12Rβ1 (Fig 4A) . All data points are shown and the differences between 423 the means of the ΔTM-IL-12Rβ1 signal for each group determined by ANOVA with Tukey's multiple 424 comparison, n=6-31, *P<0.05, **P<0.01, ***P<0.001. RNA-Seq data sets from a UK cohort was analyzed 425
for expression of the ΔTM-IL-12Rβ1 (Fig 4B) (all data points are shown with known group outliers shown 426 as open symbols) and was discriminatory for controls versus both LTB and PTB, using ANOVA with 427
Tukey's multiple comparison, n=12-21, *P<0.05, **P<0.01. RNA was taken from a new cohort in China 428
and analyzed for expression of all IL-12Rβ1 transcripts and was shown to discriminate between controls 429 and LTB and PTB, between LTB and PTB and between PTB and pneumonia, using ANOVA with Tukey's 430 multiple comparison, all data points are shown, n=20, *P<0.05, ***P<0.001. 431 values at 0 and 6 or 8 week and 0 and 26 or 52 weeks for each patient. In the UK and China (top graphs) 437 significant differences in the means were observed after treatment whereas no discernable effect could 438 be seen in the South African cohorts undergoing treatment, n=7-27 P<0.05, **P<0.01. 439
13.
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Cai China GSE 54992 ΔTM: Probe intensity for ΔTM-IL-12Rβ1 isoform, All: Intensity of probe specific for both isoforms of 12Rβ1; Full: Intensity of probe specific for full length 12Rβ1 isoform.
